Definium Therapeutics (DFTX) Prepaid Assets (2020 - 2026)
Definium Therapeutics (DFTX) posted quarterly Prepaid Assets of $7.1 million for Q1 2026, down 22.88% year-over-year from $9.3 million in Q1 2025, and down 7.58% quarter-over-quarter from $7.7 million in Q4 2025.
Analysis
Definium Therapeutics (DFTX) Prepaid Assets (2020 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has reported Prepaid Assets for 7 consecutive years, with $7.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 22.88% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $7.1 million (down 22.88% YoY), while the FY2025 annual figure was $7.7 million, down 1.93% from the prior year.
- Prepaid Assets eased to $7.1 million in Q1 2026 per DFTX's latest filing, from $7.7 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $9.3 million in Q1 2025 and bottomed at $1.8 million in Q3 2022.
- Historically, Prepaid Assets has averaged $4.8 million across 5 years, with a median of $4.1 million in 2024.
- Annual changes were most pronounced in 2025 — Prepaid Assets jumped 194.97% — and 2026, when it fell 22.88%.
- Definium Therapeutics' Prepaid Assets stood at $3.9 million in 2022, then rose by 6.52% to $4.2 million in 2023, then surged by 89.04% to $7.9 million in 2024, then dropped by 1.93% to $7.7 million in 2025, then fell by 7.58% to $7.1 million in 2026.
- Business Quant data shows DFTX's Prepaid Assets at $7.1 million in Q1 2026, $7.7 million in Q4 2025, and $6.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Definium Therapeutics | 4.23 Bn | 4.23 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.22 Mn |
| Mar 31, 2026 | 7.14 Mn |
| Dec 31, 2025 | 7.73 Mn |
| Sep 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 6.14 Mn |
| Mar 31, 2025 | 9.26 Mn |
| Dec 31, 2024 | 7.88 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | 3.14 Mn |
| Dec 31, 2023 | 4.17 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | 3.91 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 3.17 Mn |
| Mar 31, 2022 | 2.76 Mn |
| Dec 31, 2021 | 3.68 Mn |
| Dec 31, 2020 | 1.43 Mn |